Xagenic
closedMolecular diagnostics company developing a true point- of-care platform.
Launch date
Market cap
-
Enterprise valuation
€55—82m (Dealroom.co estimates Jul 2015.)
Toronto Ontario (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$2.2m | Seed | ||
N/A | Seed | ||
$10.0m | Series A | ||
$990k | Grant | ||
N/A | $9.6m | Early VC | |
$25.5m | Series B | ||
$15.0m | Series B | ||
Total Funding | €57.5m |
Related Content
Recent News about Xagenic
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.